A

Arcus Biosciences

484 employees

Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

Basic info

Industry

biotechnology research

Sectors

Immuno-oncology
Clinical Trials
Pharmaceutical
Biotechnology
Therapeutics
Protein Therapeutics
Medicinal Chemistry
Biopharma
Medical
Health Care
Large Molecule Drug Discovery

Date founded

2015

Funding rounds raised

Total raised

$220M

from 16 investors over 16 rounds

A

Arcus Biosciences raised $220M on February 1, 2021

Investors: Gilead Sciences

A

Arcus Biosciences raised $200M on May 28, 2020

Investors: Gilead Sciences

A

Arcus Biosciences raised $107M on November 13, 2017

Investors: Leerink Partners LLC, Research Division, The Column Group, GV, The Invus Group, Hillhouse Capital Management, Wellington Management and Foresite Capital

A

Arcus Biosciences raised $70M on September 1, 2016

Investors: GV, Foresite Capital, The Invus Group, The Column Group and Celgene

A

Arcus Biosciences raised $50M on May 1, 2015

Investors: Celgene and The Column Group

FAQ